Lazaro P, de Salamanca R E, Elder G H, Villaseca M L, Chinarro S, Jaqueti G
Br J Dermatol. 1984 May;110(5):613-7. doi: 10.1111/j.1365-2133.1984.tb04687.x.
A patient with hepatoerythropoietic porphyria (HEP) is described. He was shown by a family study to be homozygous for a gene that causes greater than 95% suppression of erythrocyte uroporphyrinogen decarboxylase activity.
本文描述了一名患有肝红细胞生成性卟啉症(HEP)的患者。通过家系研究表明,他对于一种导致红细胞尿卟啉原脱羧酶活性被抑制超过95%的基因是纯合子。